Sterimedix Strategy Drives Growth into Foreign Markets

During their attendance at Arab Health in their strategy to drive ongoing growth into foreign markets, will demonstrate how they have developed into a global trailblazer in the creation of ophthalmic and aesthetic cannulas.

So far, their industry success has been down to their aptitude to blend cutting-edge technology with a consistent manufacturing calibre upheld throughout production of their disposable cannulas.

The company was founded more than 30 years ago, manufacturing 100 million cannulas over the last decade, and remaining to be the sole European producer of these products for ophthalmics.

They started making disposable aesthetic cannulas and sharp needles using the Silkann brand at the start of this century as the market for injectable implants developed. Since then, demand has shifted towards orthopaedic applications.

Their emphasis on excellence combined with their capacity for large-scale production is primarily why Streimedix had seen exceptional triumph on a worldwide scale.

A group of their experts will be on hand at the Medilink UK Pavilion to answer questions about the product line and talk about recent advancements in the sector.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.